Form 4: Frederic Moll Reports Acquisition of Procept BioRobotics Corp Stock and Stock Options

Director Frederic Moll reports acquisition of restricted stock units and stock options in Procept BioRobotics Corp.

Summary

• On June 4, 2024, Frederic Moll, a director of Procept BioRobotics Corp, acquired 1,376 restricted stock units (RSUs) and 2,526 stock options.
• The RSUs vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, contingent upon continued service.
• The stock options, with an exercise price of $67.29, also vest in full on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting following the grant date, contingent upon continued service.
• Following these transactions, Moll beneficially owns 809,609 shares of common stock and 2,526 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it primarily reports transactions. The acquisition of shares and options by a director can be seen as a mildly positive sign, but it's a routine disclosure.

Positives

• The acquisition of RSUs and stock options by a director signals confidence in the company's future performance.
• The vesting conditions tied to continued service align the director's interests with those of the shareholders.

Future Outlook

The vesting of the RSUs and stock options is contingent upon continued service, suggesting an expectation of ongoing involvement by the director.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders, allowing investors to monitor the actions of those with privileged information.

Stakeholder Impact

• The transactions may have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates